Navigation Links
Breast Cancer Patients Take DNA Test to Determine Best Treatment
Date:10/30/2008

SEATTLE, Oct. 30 /PRNewswire/ -- Nearly one third of breast cancer patients prescribed tamoxifen currently fail treatment. According to the National Foundation for Cancer Research (NFCR), this failure rate can be reduced to less than ten percent, saving 20,000 lives each year, by having patients take a simple DNA test and properly managing their medications.

Recent research shows that tamoxifen has to be activated into endoxifen by the liver enzyme CYP2D6. Endoxifen is the medicine that prevents the recurrence of estrogen receptive positive cancers.

About ten percent of breast cancer patients prescribed tamoxifen are missing CYP2D6 because of their DNA, and will fail tamoxifen treatment. "Patients want to know that tamoxifen will definitely benefit them, before committing to take it for five years. DNA testing offers them the reassurance that their tamoxifen is effective," stated Dr. Michael Benjamin, oncologist and editor of the medical news website, InteractMD.com

Breast cancer patients can also fail tamoxifen treatment by unknowingly taking other prescription drugs, herbals preparations, or over-the-counter medicines that interfere with CYP2D6 activity. Many classes of drugs, including anti-depressants, prevent CYP2D6 from converting tamoxifen into endoxifen. That's why Genelex includes password-protected access to their GeneMedRx software program with each test. Patients enter all of the drugs they take and produce a report to learn if any of the drugs they take might be defeating their endoxifen treatment.

"Patients and physicians need to be aware that DNA testing for tamoxifen effectiveness is available now. There is typically a 10-year gap between research and application in the clinical setting. We need to shorten that time when people's lives are at stake -- as they are with tamoxifen," stated Genelex founder and CEO Howard Coleman.

For more information about the CYP2D6 DNA test, visit Genelex at

SOURCE Genelex Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Imaging Diagnostic Systems New Laser Breast Imaging Scanner Introduced in Malaysia
4. NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
5. Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System
6. Cellumen Establishes Collaboration in Breast Cancer Patient Stratification
7. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
8. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
9. FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
10. Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer
11. Agencourt Genomic Services is Key Collaborator in New Research That Further Defines Landscape of Breast and Colon Cancers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...ss., Nov. 7, Research projects in ...op marks this evening, as Tim Kunisky of Livingsto...) Chen of Audubon, PA received the highest honors ...etition in Math, Science & Technology, the nat..., ( http://www.newscom.com/cgi-bin/prnh/20070904...
(Date:11/6/2009)..., Nov. 6 Myriant Technologies LLC ...nd manufacturer of renewable bio-chemicals, Uhde ...y provider Uhde GmbH, one of the world,s leading e... an alliance for the engineering, procurement &...c Acid plants based on renewable feedstocks. The ...
(Date:11/6/2009)... 6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc...pany") today announced updated results from a Phas...with sarcomas metastatic to the lung in a poster p...ncology Society Meeting held in Miami Beach, Flori...ion, entitled "A Phase II Study of Intravenous REO...
(Date:11/5/2009)... Md., Nov. 5 GenVec, Inc...esults for the third quarter ended September 30, 2...0.04 per share) for the three months ended Septemb... ($0.08 per share) in the comparable quarter of 20...GenVec,s net loss was $14.1 million ($0.15 per sha...
Breaking Biology Technology:Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...nighter has never been so profitable for a team of... students who won a venture capital (VC) competiti...ci, all MBA students, secured the win from a panel... prize. , ,The new competition, called Venture Cap...in the role of venture capitalists and compliments...
...hnologies Inc , a maker of molecular diagnostic pr...der 2D6 analysis panel, which provides clinical tr...harmacogenetic assays available for the important ...g solution that offers clinical trial laboratories... panel is being used to increase the likelihood of...
...peting together to race the fastest cars they can ...engineers, scientists and technicians from Ohio St...Truck , the goal is to win the $1 million dollar g...nd Challenge . , ,The Defense Advanced Research P... to reward advanced technology achievements that c...
Other Biology Technology:VC Contest Winners Learn from Experience 2Third Wave Releases Gene Test 2Oshkosh Truck Teams with OSU to Compete in DARPA Million Dollar Tech Derby 2Oshkosh Truck Teams with OSU to Compete in DARPA Million Dollar Tech Derby 3
(Date:11/6/2009)...e 150th anniversary this month of the publication ...e of Biological Sciences (AIBS) is publishing open...arwin and his historic insights into evolution. ,...rsity of California, Berkeley, and James T. Costa ..."Ten Myths About Charles Darwin," appeared in the ...
(Date:11/6/2009)...ovember 06, 2009) The Monell Center and the Chine...eijing International Meeting on Taste and Smell Re...the CAS, the meeting will be the first internation... , Alan Leshner, Chief Executive Officer, Americ...Executive Publisher of Science magazine, will open...
(Date:11/5/2009)...ersity has been awarded a training grant in the am...ion under its Integrative Graduation Education and...rst IGERT grant to be awarded to Kent State. The g...and Reinvestment Act of 2009, runs through 2014. ,...n environment aquatic resource sensing (EARS). The...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Infant Head Flattening Linked to Ear Infections 58248 1Infant Head Flattening Linked to Ear Infections 58248 2LS9 Secures 2425 Million in Latest Round of Funding 14250 1LS9 Secures 2425 Million in Latest Round of Funding 14250 2LS9 Secures 2425 Million in Latest Round of Funding 14250 3Sickday Medical House Calls Launches Low Cost Neighborhood Service For Uninsured New Yorkers 58244 1Sickday Medical House Calls Launches Low Cost Neighborhood Service For Uninsured New Yorkers 58244 2Sickday Medical House Calls Launches Low Cost Neighborhood Service For Uninsured New Yorkers 58244 3
...ade with inexpensive, off-the-shelf electronics –?... University of California, Santa Barbara. Two loca...ipated in the discovery. The potential application...rrorism detection and important medical uses. , Th...collected data shown in a graph in the scientific ...
...g the world green, because they keep the numbers o... research team lead by John Terborgh, a professor ...olas School of the Environment and Earth Sciences....logy,s oldest and thorniest questions: why is the ...ing theory that plants protect themselves from her...
...res introduced to combat its spread by infecting a...here in hospital wards, according to new research ...y. , Scientists from the University of Bath have s... of amoeba, called Acanthamoeba polyphaga, which i...n inanimate objects such as vases, sinks and walls...
Other Biology News:Portable cocaine sensor developed at UC Santa Barbara 2Portable cocaine sensor developed at UC Santa Barbara 3Predators keep the world green, ecologists find 2Predators keep the world green, ecologists find 3MRSA use amoeba to spread, new research shows 2
SYBR Green I Nucleic Acid Gel Stain from Roche Applied Science
Mouse Anti-Human PRDM2 Polyclonal Antibody, Unconjugated from Novus Biologicals
Rabbit Anti-Human S14G-Humanin Polyclonal Antibody, Unconjugated from Cosmo Bio Co., Ltd.
...terface for data capture, recording, manipulation,...nsition from paper to this powerful solution is ne... LIMS, notary service, customer definable forms an...to achieve in seconds what takes hours in many res...
Biology Products: